Alireza Zali to Inflammatory Bowel Diseases
This is a "connection" page, showing publications Alireza Zali has written about Inflammatory Bowel Diseases.
Connection Strength
1.141
-
V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. J Cell Biochem. 2019 09; 120(9):15746-15755.
Score: 0.226
-
Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microb Pathog. 2018 Apr; 117:285-289.
Score: 0.208
-
Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease. Anaerobe. 2018 Apr; 50:93-100.
Score: 0.207
-
Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis. 2017 Dec; 36(12):2335-2342.
Score: 0.199
-
The first study on opportunistic intestinal microsporidiosis in IBD patients receiving immunosuppressive medications in Iran. Epidemiol Infect. 2017 07; 145(10):2095-2099.
Score: 0.197
-
The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol. 2018 11; 233(11):8754-8766.
Score: 0.053
-
Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018 Jan; 54:86-94.
Score: 0.051